In the initial phase of BEMOTHER, our primary focus has been on participant recruitment and ensuring that the experimental sessions adhere to predetermined standards of quality and quantity for effective data acquisition.
As we reach the mid-term of the project, we have successfully recruited 322 nulliparous women who are planning to conceive. Among them, 127 participants have already completed a comprehensive pregnancy and postpartum session, which represents 92% of our original target. Additionally, we have successfully recruited 56 same-sex partners, nearly reaching our initial goal of 60.
We have also been able to collect all the intended measures, including neuroimaging, psychological assessments, behavioral data, and metabolomics measurements for each session. This encompasses one pre-pregnancy session, two intra-pregnancy sessions, and three postpartum sessions as per our planned protocol.
Regarding neuroimaging data, we have acquired over 1,300 functional and structural scans MRI scans, that will allow us to characterize the evolution of the morphometric, tractographic, neuroplastic, and connectivity variables over pregnancy and the postpartum period. This an outstanding achievement in itself, since it represents the world’s largest neuroimaging dataset on the neural reorganization of a woman’s transition to motherhood. Right now, we are beginning the analyses of the first four data points of our neuroimaging data (i.e. before pregnancy, 18 and 36 weeks of pregnancy, and 1 month postpartum).
We have also successfully gathered all the originally planned neuropsychological measures, ensuring a comprehensive assessment of our participants. These measures encompass: a) demographical and obstetric data, as well as physical and psychological health measures, b) a complete neuropsychological evaluation, including general and social cognition measures, psychiatric data, as well as mother-infant bonding measures.
Lastly, we have also successfully conducted metabolomics analyses, specifically focusing on determining the concentrations of approximately 100 steroid hormones and metabolites in urine samples. This comprehensive set of steroid hormones includes the primary metabolites of progestogens, estrogens, androgens, and corticosteroids.